Literature DB >> 8258961

Long-term glycemic control and the rate of progression of early diabetic kidney disease.

R E Gilbert1, C Tsalamandris, L A Bach, S Panagiotopoulos, R C O'Brien, T J Allen, I Goodall, V Young, E Seeman, R M Murray.   

Abstract

In this prospective study of 11.9 years duration (range 9 to 14), we examined the progression of albuminuria prior to and after the onset of microalbuminuria [albumin excretion rate (AER): 20 to 200 micrograms/minute]. Glycated hemoglobin (HbA1), AER and blood pressure were measured every six months. Twenty-two (13 type I, 9 type II) patients were identified in whom AER increased progressively (progressors). These patients were compared with 22 others matched for age, duration and type of diabetes in whom AER did not change significantly during the study period (non-progressors). In the progressors, the rate of increase in AER correlated with mean HbA1 for the study period in patients with type I (r = 0.68, P < 0.01) and type II diabetes (r = 0.71, P < 0.05). Furthermore, AER began increasing well before the conventional 20 micrograms/minute threshold of microalbuminuria had been reached and within the first five years of diagnosis of type I diabetes. We conclude that in predisposed diabetic patients, long-term glycemic control is correlated with the rate of development of early renal abnormalities. Repeated measurements of AER from the time of diagnosis may be useful in the early detection of patients who will develop microalbuminuria and ultimately overt diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258961     DOI: 10.1038/ki.1993.322

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

Review 1.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

2.  Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control.

Authors:  Claudia P Sanmiguel; Jeffrey L Conklin; Scott A Cunneen; Philip Barnett; Edward H Phillips; Mark Kipnes; John Pilcher; Edy E Soffer
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype.

Authors:  C W Heilig; L A Concepcion; B L Riser; S O Freytag; M Zhu; P Cortes
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

Review 4.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

Review 5.  Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life.

Authors:  M E Cooper; D Vranes; J R Rumble
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

6.  Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.

Authors:  R G Langham; D J Kelly; R M Gow; Y Zhang; A J Cox; W Qi; K Thai; C A Pollock; P K Christensen; H-H Parving; R E Gilbert
Journal:  Diabetologia       Date:  2008-02-16       Impact factor: 10.122

Review 7.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.

Authors:  A Schmitz; M Vaeth; C E Mogensen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

9.  Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number.

Authors:  C He; C Esposito; C Phillips; R K Zalups; D A Henderson; G E Striker; L J Striker
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

10.  Diabetic nephropathy. Mechanisms of mesangial matrix expansion.

Authors:  C K Abrass
Journal:  West J Med       Date:  1995-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.